[1]
“Pharmacodynamic Evaluation Of Moxonidine For Immunomodulatory And Anti-Inflammatory Potentials Via NF-Κb Signaling Pathway Modulation”, Int. J. Environ. Sci., pp. 1025–1033, Jul. 2025, doi: 10.64252/3ywffq59.